These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23483986)

  • 1. The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes.
    Dowling DJ; Tan Z; Prokopowicz ZM; Palmer CD; Matthews MA; Dietsch GN; Hershberg RM; Levy O
    PLoS One; 2013; 8(3):e58164. PubMed ID: 23483986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Imidazoquinoline Toll-Like Receptor-7/8 Agonist Hybrid-2 Potently Induces Cytokine Production by Human Newborn and Adult Leukocytes.
    Ganapathi L; Van Haren S; Dowling DJ; Bergelson I; Shukla NM; Malladi SS; Balakrishna R; Tanji H; Ohto U; Shimizu T; David SA; Levy O
    PLoS One; 2015; 10(8):e0134640. PubMed ID: 26274907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways.
    Philbin VJ; Dowling DJ; Gallington LC; Cortés G; Tan Z; Suter EE; Chi KW; Shuckett A; Stoler-Barak L; Tomai M; Miller RL; Mansfield K; Levy O
    J Allergy Clin Immunol; 2012 Jul; 130(1):195-204.e9. PubMed ID: 22521247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC.
    Lu H; Dietsch GN; Matthews MA; Yang Y; Ghanekar S; Inokuma M; Suni M; Maino VC; Henderson KE; Howbert JJ; Disis ML; Hershberg RM
    Clin Cancer Res; 2012 Jan; 18(2):499-509. PubMed ID: 22128302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.
    Dowling DJ; Scott EA; Scheid A; Bergelson I; Joshi S; Pietrasanta C; Brightman S; Sanchez-Schmitz G; Van Haren SD; Ninković J; Kats D; Guiducci C; de Titta A; Bonner DK; Hirosue S; Swartz MA; Hubbell JA; Levy O
    J Allergy Clin Immunol; 2017 Nov; 140(5):1339-1350. PubMed ID: 28343701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity.
    Dietsch GN; Lu H; Yang Y; Morishima C; Chow LQ; Disis ML; Hershberg RM
    PLoS One; 2016; 11(2):e0148764. PubMed ID: 26928328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity.
    Du J; Wu Z; Ren S; Wei Y; Gao M; Randolph GJ; Qu C
    Vaccine; 2010 Aug; 28(38):6273-81. PubMed ID: 20637759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells.
    Levy O; Suter EE; Miller RL; Wessels MR
    Blood; 2006 Aug; 108(4):1284-90. PubMed ID: 16638933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulatory activity of Toll-like receptor 8 agonists towards human leucocytes: basic mechanisms and translational opportunities.
    Philbin VJ; Levy O
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1485-91. PubMed ID: 18031250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of TLR8 and TLR4 agonists reduces the degrading effects of nicotine on DC-NK mediated effector T cell generation.
    Nouri-Shirazi M; Tamjidi S; Nourishirazi E; Guinet E
    Int Immunopharmacol; 2018 Aug; 61():54-63. PubMed ID: 29803914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant.
    van Haren SD; Ganapathi L; Bergelson I; Dowling DJ; Banks M; Samuels RC; Reed SG; Marshall JD; Levy O
    Cytokine; 2016 Jul; 83():99-109. PubMed ID: 27081760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.
    Gorden KB; Gorski KS; Gibson SJ; Kedl RM; Kieper WC; Qiu X; Tomai MA; Alkan SS; Vasilakos JP
    J Immunol; 2005 Feb; 174(3):1259-68. PubMed ID: 15661881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR agonist combinations that stimulate Th type I polarizing responses from human neonates.
    Surendran N; Simmons A; Pichichero ME
    Innate Immun; 2018 May; 24(4):240-251. PubMed ID: 29673285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
    Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
    J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR8 combined withTLR3 or TLR4 agonists enhances DC-NK driven effector Tc1 cells.
    Nouri-Shirazi M; Tamjidi S; Nourishirazi E; Guinet E
    Immunol Lett; 2018 Jan; 193():58-66. PubMed ID: 29103998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR8 stimulation enhances cetuximab-mediated natural killer cell lysis of head and neck cancer cells and dendritic cell cross-priming of EGFR-specific CD8+ T cells.
    Stephenson RM; Lim CM; Matthews M; Dietsch G; Hershberg R; Ferris RL
    Cancer Immunol Immunother; 2013 Aug; 62(8):1347-57. PubMed ID: 23685782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline, dexamethasone and azithromycin demonstrate distinct age-dependent and synergistic inhibition of TLR- and inflammasome-mediated cytokine production in human newborn and adult blood in vitro.
    Speer EM; Dowling DJ; Xu J; Ozog LS; Mathew JA; Chander A; Yin D; Levy O
    PLoS One; 2018; 13(5):e0196352. PubMed ID: 29715306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization.
    van Haren SD; Dowling DJ; Foppen W; Christensen D; Andersen P; Reed SG; Hershberg RM; Baden LR; Levy O
    J Immunol; 2016 Dec; 197(11):4413-4424. PubMed ID: 27793997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice.
    Rostamian M; Niknam HM
    Mol Immunol; 2017 Nov; 91():202-208. PubMed ID: 28963929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells.
    Hurst J; Prinz N; Lorenz M; Bauer S; Chapman J; Lackner KJ; von Landenberg P
    Immunobiology; 2009; 214(8):683-91. PubMed ID: 19249118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.